Frequency and clinical and molecular aspects of familial hypercholesterolemia in an endocrinology unit in Ciudad Bolívar, Venezuela

• Published in: Endocrinología, diabetes y nutrición. Vol. 64; no. 8; pp. 432 - 439
• Main Authors: Lima-Martínez, Marcos M, Paoli, Mariela, Vázquez-Cárdenas, Alejandra, Magaña-Torres, María Teresa, Guevara, Ornella, Muñoz, María Carolina, Parrilla-Alvarez, Alberto, Márquez, Yuliangelys, Medeiros, Ana, Bourbon, Mafalda
• Format: Journal Article
• Language: English
• Published: Elsevier España, S.L.U 01.10.2017
• Subjects: Cholesterol; Colesterol; Endocrinology; Endocrinology and Metabolism; Endocrinología; Familial hypercholesterolemia; Hipercolesterolemia familiar; Venezuela; Xanthomas; Xantomas; Xantomas; Venezuela; Hipercolesterolemia familiar; Colesterol; Endocrinología; Familial hypercholesterolemia; Xanthomas; Endocrinology; Cholesterol
• ISSN: 2530-0180; 2530-0180
• DOI: 10.1016/j.endien.2017.10.004

Abstract Objective To assess the frequency and the clinical, biochemical, and molecular aspects of familial hypercholesterolemia (FH) in subjects attending an endocrinology unit. Methods An observational, descriptive study evaluating 3140 subjects attending the endocrinology unit of Centro Médico Orinoco in Ciudad Bolívar, Venezuela, from 7 January 2013 to 9 December 2016. The index cases were selected using the Dutch Lipid Clinic Network criteria. Plasma lipid levels were measured, and a molecular analysis was performed by DNA sequencing of the LDLR and APOB genes. Results Ten (0.32%) of the 3140 study patients had clinical and biochemical characteristics consistent with FH. All but one were female. Three had first-degree relatives with prior premature coronary artery; and none had a personal history of this condition. Three patients were obese; three had high blood pressure; and no one suffered from diabetes. Three patients had a history of tendon xanthomas, and one of corneal arcus. LDL-C levels ranged from 191 to 486 mg/dl. Two patients were on statin therapy. The genetic causes of FH were identified in four patients, and were LDLR gene mutations in three of them and an APOB gene mutation in exon 26 in the other. Conclusion Approximately, one out of every 300 people attending this endocrinology unit in those four years had FH, and LDLR gene mutations were the most prevalent cause.